Press Releases

February 26, 2020

Summary Toggle Endo Reports Fourth-Quarter And Full-Year 2019 Financial Results
February 19, 2020

Summary Toggle Endo Names Blaise Coleman President and Chief Executive Officer
February 19, 2020

Summary Toggle Endo Appoints Mark G. Barberio to Board of Directors
January 27, 2020

Summary Toggle Endo Begins Shipment of Authorized Generic Version of Carafate® (sucralfate) Oral Suspension in the United States
January 24, 2020

Summary Toggle Endo to Announce Fourth-Quarter and Full-Year 2019 Financial Results
January 10, 2020

Summary Toggle Endo Settles Opioid Investigation with State of Oklahoma for $8.75 million
December 17, 2019

Summary Toggle Endo to Participate at J.P. Morgan Healthcare Conference
December 10, 2019

Summary Toggle Endo Launches Generic Version of Afinitor® (everolimus) Tablets in the United States
November 22, 2019

Summary Toggle Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference
November 19, 2019

Summary Toggle Endo Announces FDA's Acceptance of Original Biologics License Application (BLA) for Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite
November 4, 2019

Summary Toggle Endo Reports Third-Quarter 2019 Financial Results
November 4, 2019

Summary Toggle Endo Implements CEO Succession Plan
October 28, 2019

Summary Toggle Endo Aesthetics Launches New Campaign Elevating Artistry Through Scientific Innovation
October 25, 2019

Summary Toggle Endo Presents New XIAFLEX® (collagenase clostridium histolyticum) Data at the 2019 Fall Meeting of the Sexual Medicine Society of North America (SMSNA)
October 24, 2019

Summary Toggle Endo Presents Data on the Use of a Standing MRI for the Evaluation of Cellulite at the American Society for Dermatologic Surgery (ASDS) Annual Meeting
October 2, 2019

Summary Toggle Endo to Announce Third-Quarter 2019 Financial Results
September 30, 2019

Summary Toggle Endo Announces Successful Culmination of Litigation Regarding FDA Compounding Policy
September 6, 2019

Summary Toggle Endo Announces Submission of Biologics License Application to FDA for Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite
September 5, 2019

Summary Toggle Endo Announces Execution of Final Settlement Agreement and Release Resolving "Track 1" Opioid Cases
September 5, 2019

Summary Toggle Endo to Present New XIAFLEX® (collagenase clostridium histolyticum) Data at the 2019 American Society for Surgery of the Hand's (ASSH) Annual Meeting
September 4, 2019

Summary Toggle Endo Announces Approval of First Generic Orfadin® in U.S.
September 3, 2019

Summary Toggle Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Delayed-release Tablets in the United States
August 22, 2019

Summary Toggle Football Legend John Elway Reveals He has Dupuytren's Contracture and Wants Others to Get the "Facts on Hand"
August 20, 2019

Summary Toggle Endo Announces Settlement in Principle to Resolve "Track 1" Opioid Cases
August 5, 2019

Summary Toggle Endo Reports Second-Quarter 2019 Financial Results
August 2, 2019

Summary Toggle Endo Applauds U.S. District Court Decision that Vasopressin Cannot be Used for Compounding by Outsourcing Facilities
August 1, 2019

Summary Toggle Endo Appoints Domenico Ciarico as Executive Vice President and Chief Commercial Officer, Sterile and Generics
July 31, 2019

Summary Toggle Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada
July 11, 2019

Summary Toggle Endo to Announce Second-Quarter 2019 Financial Results
June 6, 2019

Summary Toggle Nationally Recognized Urologist and Author, Aaron Spitz, MD, Teams Up with Endo Pharmaceuticals' Ask About the Curve Campaign to Encourage Men to Get "In Touch" With Their Anatomy This Men's Health Month
May 17, 2019

Summary Toggle Phase 3 Data of Collagenase Clostridium Histolyticum for the Investigational Treatment of Cellulite to Be Presented at The Aesthetic Meeting 2019
May 15, 2019

Summary Toggle Endo to Participate at RBC Healthcare Conference
May 9, 2019

Summary Toggle Endo Reports First-Quarter 2019 Financial Results
May 1, 2019

Summary Toggle Par Pharmaceutical, Inc. Issues Voluntary Nationwide Recall of One Lot of Mycophenolate Mofetil for Injection, USP Due to the Presence of a Glass Fragment Observed in One Vial of Reconstituted Product
April 10, 2019

Summary Toggle Endo to Announce First-Quarter 2019 Financial Results
April 5, 2019

Summary Toggle Endo Begins Shipment of Authorized Generic Version of PROVENTIL® (albuterol sulfate) HFA Inhalation Aerosol in the United States
March 27, 2019

Summary Toggle Endo International plc Announces Early Tender Results of its Previously Announced Cash Tender Offers and Consent Solicitations for up to $1.5 billion Aggregate Purchase Price of its Outstanding Senior Notes
March 19, 2019

Summary Toggle Endo Announces Publication Of Collagenase Clostridium Histolyticum (CCH) Phase 2 Data In Dermatologic Surgery
March 14, 2019

Summary Toggle Endo International plc Announces an Upsizing of its Cash Tender Offers and Consent Solicitations
March 14, 2019

Summary Toggle Endo International plc Announces Pricing of Private Offering Of Senior Secured Notes
March 14, 2019

Summary Toggle Endo International plc Announces Debt Refinancing Transactions, Including Cash Tender Offers and Consent Solicitations for up to $1.0 billion Aggregate Purchase Price of its Outstanding Senior Notes
March 14, 2019

Summary Toggle Endo International plc Announces Proposed Private Offering Of Senior Secured Notes
March 4, 2019

Summary Toggle Endo to Participate at Cowen & Company 39th Annual Healthcare Conference
March 1, 2019

Summary Toggle Endo Announces FDA Decision Not to Include Vasopressin on 503B Bulks List
March 1, 2019

Summary Toggle Endo Will Showcase Late-Breaking Phase 3 CCH Data at the 2019 American Academy of Dermatology Annual Meeting
February 28, 2019

Summary Toggle Endo Reports Fourth-Quarter And Full Year 2018 Financial Results
February 27, 2019

Summary Toggle Endo Announces Termination of Acquisition Agreements with Somerset Therapeutics and Business of Affiliate Wintac Limited
February 22, 2019

Summary Toggle Paladin Labs Inc. Announces Approval of Envarsus PA™ (tacrolimus prolonged-release tablets) in Canada
February 7, 2019

Summary Toggle Endo Agrees Not To Oppose Additional Stay of FDA Litigation Following Restoration of Government Appropriations
January 25, 2019

Summary Toggle Endo to Announce Fourth-Quarter and Full-Year 2018 Financial Results
December 31, 2018

Summary Toggle Endo Announces Anticipated Further Stay of Compounding Litigation Due to Lapse of Government Appropriations
December 19, 2018

Summary Toggle Endo to Participate at J.P. Morgan Healthcare Conference
November 28, 2018

Summary Toggle Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference
November 26, 2018

Summary Toggle Endo to Participate at Piper Jaffray Global Healthcare Conference
November 8, 2018

Summary Toggle Endo Reports Third-Quarter 2018 Financial Results
November 7, 2018

Summary Toggle Endo Announces Positive Results from Phase 3 Studies of Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite
October 11, 2018

Summary Toggle Endo Presents Data on the Perception and Measurement of Cellulite Severity at the American Society for Dermatologic Surgery (ASDS) Annual Meeting
September 28, 2018

Summary Toggle Endo to Announce Third-Quarter 2018 Financial Results
September 28, 2018

Summary Toggle Endo Pharmaceuticals Issues Voluntary Nationwide Recall for Two Lots of Robaxin® 750mg Tablets 100 Count Bottle Packs Due to Incorrect Daily Dosing Information on Label
September 24, 2018

Summary Toggle Endo Agrees to Additional Stay of FDA Litigation Following FDA's Commitment to Use Best Efforts to Finalize Vasopressin Clinical Need Determination By Year End
September 6, 2018

Summary Toggle Endo to Participate at Morgan Stanley Global Healthcare Conference
August 15, 2018

Summary Toggle Endo Lifts Temporary Stay of FDA Litigation Following the Launch of a Bulk-Compounded Vasopressin Product by a Section 503B Outsourcing Facility
August 9, 2018

Summary Toggle PGA Golfer Tim Herron Teams Up with Endo Pharmaceuticals to Encourage Parents to Get Their Own Check-Ups This Back-to-School Season
August 8, 2018

Summary Toggle Endo Reports Second-Quarter 2018 Financial Results
August 2, 2018

Summary Toggle Endo Announces Appointment of Laure Park as Senior Vice President, Investor Relations and Corporate Affairs
July 27, 2018

Summary Toggle Endo Begins Shipment of Authorized Generic Version of INVANZ® (ertapenem for injection) in the United States
July 25, 2018

Summary Toggle Bioprojet and Endo Jointly Announce Agreement for Paladin Labs Inc. to Commercialize Pitolisant in Canada
July 20, 2018

Summary Toggle Endo to Announce Second-Quarter 2018 Financial Results
July 2, 2018

Summary Toggle Endo Begins Shipment of Authorized Generic Version of Colcrys® (colchicine, USP) in the United States
June 11, 2018

Summary Toggle Endo Announces Master Settlement Agreement Allowing for Resolution of Known Testosterone Replacement Therapy Product Liability Claims and Entry of Significant Case Management Order
May 8, 2018

Summary Toggle Endo Reports First-Quarter 2018 Financial Results
May 2, 2018

Summary Toggle Endo to Participate at the UBS Global Healthcare Conference
April 27, 2018

Summary Toggle Collagenase Clostridium Histolyticum For The Investigational Treatment Of Cellulite To Be Featured During The Hot Topics Symposium At The Aesthetic Meeting 2018
April 26, 2018

Summary Toggle Endo to Acquire Somerset Therapeutics and Business of Affiliate Wintac Limited
April 23, 2018

Summary Toggle Paladin Labs Inc. Announces Launch of New Indication for XIAFLEX® (Collagenase Clostridium Histolyticum), Broadening Its Use to the Treatment of Appropriate Patients with Peyronie's Disease
April 19, 2018

Summary Toggle Paladin Labs Announces the Launch of Unisom® Snore Relief, the Only Natural Health Product Throat Spray Available in Canada to Help Relieve Symptoms Associated with Snoring
April 17, 2018

Summary Toggle Endo Receives Paragraph IV Notification on Vasostrict®
April 13, 2018

Summary Toggle Endo to Announce First-Quarter 2018 Financial Results
April 2, 2018

Summary Toggle Endo Agrees to Extend Temporary Stay of FDA Litigation
March 1, 2018

Summary Toggle Endo Obtains Preliminary Injunction Against QuVa Pharma, Inc. Preventing Marketing and Release of Vasopressin Product
February 27, 2018

Summary Toggle Endo Reports Fourth-Quarter And Full-Year 2017 Financial Results
February 6, 2018

Summary Toggle Endo Announces Initiation Of Two Pivotal Phase 3 Clinical Trials Of Collagenase Clostridium Histolyticum For The Treatment Of Cellulite
January 29, 2018

Summary Toggle Endo to Announce Fourth-Quarter 2017 Financial Results
January 24, 2018

Summary Toggle Endo Agrees to FDA's Request to Seek Temporary Litigation Stay
January 11, 2018

Summary Toggle Endo Comments on United States Attorney's Office Grand Jury Subpoena Relating to Products Containing Oxymorphone
December 28, 2017

Summary Toggle Endo to Participate at the 36th Annual J.P. Morgan Healthcare Conference
November 17, 2017

Summary Toggle Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference
November 9, 2017

Summary Toggle Endo Reports Third-Quarter 2017 Financial Results
November 8, 2017

Summary Toggle Endo Announces Appointment of Dr. Sharad S. Mansukani to Board of Directors and Resignation of Mr. Douglas S. Ingram
October 30, 2017

Summary Toggle Endo Announces Certain Preliminary Financial Results for Third-Quarter 2017 and Affirms Selected 2017 Financial Guidance
October 26, 2017

Summary Toggle Endo Files Federal Lawsuit to Obtain FDA Compliance with Drug Quality and Security Act of 2013
October 25, 2017

Summary Toggle Endo Completes Divestiture of Grupo Farmacéutico SOMAR
October 9, 2017

Summary Toggle Endo to Announce Third-Quarter 2017 Financial Results
September 26, 2017

Summary Toggle Four-Time PGA TOUR Winner Tim Herron Teams Up with Endo Pharmaceuticals to Encourage Adults to Get the Facts on Hand
August 28, 2017

Summary Toggle Endo Begins Shipment of Generic Sabril® (vigabatrin) for Oral Solution
August 22, 2017

Summary Toggle Endo to Participate at Morgan Stanley Global Healthcare Conference
August 8, 2017

Summary Toggle Endo Reports Second-Quarter 2017 Financial Results
August 7, 2017

Summary Toggle Endo Announces Agreements to Resolve Virtually All Known U.S. Mesh Product Liability Claims
July 21, 2017

Summary Toggle Endo to Restructure Manufacturing Network
July 14, 2017

Summary Toggle Endo to Announce Second-Quarter 2017 Financial Results